Back to Search Start Over

High immune activation and abnormal expression of cytokines contribute to death of SHIV89.6-infected Chinese rhesus macaques

Authors :
Gao-Hong Zhang
Wei Pang
Hong-Yi Zheng
Ren-Rong Tian
Lin-Tao Zhang
Lin Zhu
Ming-Xu Zhang
Xiao-Liang Zhang
Yong-Tang Zheng
Source :
Archives of Virology. 160:1953-1966
Publication Year :
2015
Publisher :
Springer Science and Business Media LLC, 2015.

Abstract

Chinese rhesus macaques (CRMs) are ideal experimental animals for studying the pathogenesis of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) and for vaccine research. SHIV89.6 has been reported to be an attenuated virus because, in most cases, SHIV89.6 infection only causes limited alteration of immune cells and tissues, and it has been used commonly for vaccine research. After two serial passages in vivo, SHIV (SHIV-89.6P) induces CD4 lymphopenia and an AIDS-like disease with wasting and opportunistic infections. However, the pathogenic ability of SHIV89.6 is not well understood. In this study, we found that 6 of 14 SHIV89.6-infected CRMs died within 127 weeks after infection. We found especially high immune activation, low IFN-α expression, and distinctive cytokine expression profiles in the infected and dead (ID) group of monkeys, while there was only few change in the CD4(+) T counts and distribution of T cell subsets in the ID group monkeys. Also, there was a similar dynamic of viral load between infected and surviving (IS) and ID group monkeys. Furthermore, we found various correlations among immune activation, IFN-α expression, and frequencies of cytokine-secreting cells. These results suggest that SHIV89.6 infections have pathogenic potential in CRMs and that high immune activation and abnormal expression of cytokines contribute to death of SHIV89.6-infected CRMs. This also implies that high immune activation may be relevant to dysfunction of immune cells. It is proposed that high immune activation and dysfunction of immune cells may be good predictors for disease progression and markers for therapy.

Details

ISSN :
14328798 and 03048608
Volume :
160
Database :
OpenAIRE
Journal :
Archives of Virology
Accession number :
edsair.doi.dedup.....04f3ba8c3748b89b9a635a00591bf4df
Full Text :
https://doi.org/10.1007/s00705-015-2455-6